MX9202389A - Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas - Google Patents

Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas

Info

Publication number
MX9202389A
MX9202389A MX9202389A MX9202389A MX9202389A MX 9202389 A MX9202389 A MX 9202389A MX 9202389 A MX9202389 A MX 9202389A MX 9202389 A MX9202389 A MX 9202389A MX 9202389 A MX9202389 A MX 9202389A
Authority
MX
Mexico
Prior art keywords
oligomeric compounds
compounds useful
imitators
disorders
bioactive macromolecules
Prior art date
Application number
MX9202389A
Other languages
English (en)
Inventor
John R Regan
Daniel G Mcgarry
Michael N Chang
Jeffrey N Barton
Jack Newman
Schmuel Ben-Sasson
Original Assignee
Rhone Poulenc Rorer Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Pharma filed Critical Rhone Poulenc Rorer Pharma
Publication of MX9202389A publication Critical patent/MX9202389A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00—Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/04—Condensation polymers of aldehydes or ketones with phenols only of aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Esta invención se refiere a compuestos oligoméricos aromáticos útiles en el tratamiento de perturbaciones cardiovasculares, metabólicas de los huesos, hipolipidémicas, neuronales, gastrointestinales y de degradación de tejido conector mediada por elastasa, y perturbaciones que pueden ser tratadas por agentes efectivos para ligar DNA, a procedimientos para la preparación de tales compuestos oligoméricos, a composiciones farmacéuticas que incluyen tales compuestos oligoméricos, y a su uso en el tratamiento de tales perturbaciones.
MX9202389A 1991-05-20 1992-05-20 Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas MX9202389A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70306191A 1991-05-20 1991-05-20

Publications (1)

Publication Number Publication Date
MX9202389A true MX9202389A (es) 1993-08-01

Family

ID=24823810

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202389A MX9202389A (es) 1991-05-20 1992-05-20 Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas

Country Status (8)

Country Link
EP (1) EP0585371B1 (es)
AT (1) ATE216247T1 (es)
AU (1) AU2010792A (es)
DE (1) DE69232557T2 (es)
DK (1) DK0585371T3 (es)
ES (1) ES2174834T3 (es)
MX (1) MX9202389A (es)
WO (1) WO1992020350A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60139025D1 (de) 2000-12-28 2009-07-30 Takeda Pharmaceutical Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
EP1394154A4 (en) 2001-03-23 2005-05-18 Takeda Pharmaceutical HETEROCYCLIC DERIVATIVE WITH FIVE MEMBERS OF ALKANOIC ACID
ATE395346T1 (de) 2003-09-16 2008-05-15 Astrazeneca Ab Chinazolinderivate als tyrosinkinaseinhibitoren
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
US10730874B2 (en) 2018-03-13 2020-08-04 Shire Human Genetic Therapies, Inc. Inhibitors of plasma kallikrein and uses thereof
PT4031547T (pt) 2019-09-18 2024-08-27 Takeda Pharmaceuticals Co Inibidores de calicreína plasmática e utilizações dos mesmos
JP2022549601A (ja) 2019-09-18 2022-11-28 武田薬品工業株式会社 ヘテロアリール血漿カリクレインインヒビター

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2323481A (en) * 1939-03-14 1943-07-06 Du Pont Chemical process and composition
US2910484A (en) * 1957-05-09 1959-10-27 Ciba Pharm Prod Inc Polyhydric-aldehyde condensation products
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
IL95353A (en) * 1989-08-14 1995-01-24 Rhone Poulenc Rorer Int Pharmaceutical preparations containing aromatic polymers
EP0502117B1 (en) * 1989-11-22 1999-06-23 Rhone-Poulenc Rorer International (Holdings) Inc. Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone
FR2672214A1 (fr) * 1991-01-31 1992-08-07 Rhone Poulenc Rorer Sa Application de polymeres biologiquement actifs, pour l'obtention d'un medicament pour le traitement d'infections a retrovirus.

Also Published As

Publication number Publication date
ATE216247T1 (de) 2002-05-15
AU2010792A (en) 1992-12-30
EP0585371A4 (en) 1994-07-13
ES2174834T3 (es) 2002-11-16
EP0585371A1 (en) 1994-03-09
DE69232557D1 (de) 2002-05-23
DK0585371T3 (da) 2002-08-12
WO1992020350A1 (en) 1992-11-26
DE69232557T2 (de) 2002-10-24
EP0585371B1 (en) 2002-04-17

Similar Documents

Publication Publication Date Title
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
ATE324900T1 (de) Polymer zur therapeutischen anwendung
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
BRPI0416809A (pt) glicosamina
DK0721501T3 (da) Farmaceutisk præparat der omfatter phosphatase eller et derivat deraf
ATE345130T1 (de) Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen
ATE140388T1 (de) Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
HK1155944A1 (en) W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
ATE350019T1 (de) Verfahren zur behandlung von kapseln und trockenen gepulverten pharmazeutischen formulierungen
EP2497478A3 (en) Oligosaccaride compositions and use thereof in the treatment of infection
ATE265857T1 (de) Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie
EP1140840A4 (en) DIPHENYLUREA WITH SUBSTITUENTS -G (V) -CARBOXYARYLES, INHIBITORS OF RAF KINASE
MX9202389A (es) Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas
DE69535673D1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ATE454896T1 (de) Heilkräuterzusammensetzung zur behandlung von aids
HK1084023A1 (en) Glycosaminoglycans for treating emotional dysfunctions
DE60004093D1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
RU98114982A (ru) Состав, содержащий диосгенин